Germany is not only Europe’s largest economy, but also its largest cannabis market. Flower remains one of the most prescribed cannabis products in Germany and demand continues to rise, despite a bottleneck of supply. In this session, you will gain insights on: The upcoming first German harvests The business of importing and distributing to pharmacies […]
Read More… from Case Study: The Success of the German Market
Regulations dictate that cultivators must maintain below a certain percentage of THC. Processing has been made more complicated with the Novel Foods Directive. In this session, you will gain insights on: The regulations specific for cultivators and processors How to maintain compliance, and what issues they need to be prepared for once the EU defines “cannabis medicine.” […]
Read More… from Profits Despite Regulation: Cultivation and Processing
Not all eyes are on Germany. There are other cannabis distribution opportunities that are growing and beginning to thrive in the complex European market. This session will explore those markets and the bounties they present to the savvy entrepreneur. In this session, you will gain insights on: Revenue opportunities in the emerging markets of Europe Regulations that will dictate opportunity in those markets How […]
Read More… from Distribution Opportunities in the Emerging Markets
Production has grown in many Mediterranean countries and remains open to expansion. With opportunities across the Union, entrepreneurs are looking for the intelligent companies with solid production histories and well-maintained licenses. In this session, you will gain insights on: Gaining your production licensing in new markets How to decide which country is appropriate for your project Where the best places are to open […]
Currently there are only a handful companies exporting medical marijuana to Europe or across borders in Europe. As Canadian companies struggle with imports into Europe, what can your company do to become the next exporter? In this session, you will gain insights on: Regulations regarding inter-European trade of cannabis What changed (or didn’t) in the past year How compliance […]
The US and Canadian markets are significantly more developed than the European markets, but after a period of irrational exuberance, the past few months have been challenging. What can the European industry learn from their North American counterparts’ mistakes? In this session, you will gain insights on: The current challenges of seeking capital and raising funds How to prepare […]
The European Commission updated the “novel foods” catalog to include derived products containing cannabinoids, which, in turn, means CBD products to be sold as food must be undergo a pre-marketing authorization. In this session, you will gain insights on: Understanding the time and resource consuming process for approval Which products can commercialized without EC authorization The risks of noncompliance […]
Read More… from Novel Food Directive: What It Means for Your Company
Denmark’s four-year medical cannabis trial program launched in January 2018 with its focus on patients and treating with dignity. The program has not been without its challenges. This session will examine the program two years later including ongoing research and lessons learned. In this session, you will gain insights on: How the government is evaluating the program The potential for an extension of the trial […]
Following GMP guidelines and maintaining compliance in an ever-evolving industry is the key to success for the medical cannabis industry in Europe and around the world. In this session, you will gain insights on: Effective strategies to staying compliant in an evolving market Best ways to manage your bottom line considering costly compliance changes Other compliance issues that go beyond obtaining EU-GMP certification […]
Without the hype or doom, this session will cover what’s happened in the global and European markets since the European Symposium last year. It will examine the trends that have impacted the industry, including the trends in the North American markets, novel food authorization, and major moves made by Canadian companies. In this session, you will gain insights on: WHO cannabis scheduling recommendations The current state of the […]
Based in Athens, Greece, Kostas helps Vitalis’ clients navigate the various European Union frameworks, select the extraction equipment suitable for their facilities and assists them in achieving EU-Good Manufacturing Practice (GMP) compliance when requested. Before joining Vitalis, he worked with Athens, Greece-based clinical research organization, Antaea as a Clinical Research Associate and Regulatory Affairs assistant, […]
Rick is a successful entrepreneur that has launched multiple ventures across the globe in several different industries. He currently serves as the CEO and Chair of Brains Bioceutical Corp., a global manufacturer and distributor of pharmaceutical grade cannabinoids. Prior to this, Rick was a co-founder and former CEO of Zenabis Global Inc., a leading Canadian […]
